Furthermore, this heterogeneity extends to AMR, where previous studies within the Latin American Research Consortium on the Genetics of PD (LARGE-PD) reported considerable variability in the prevalence of the LRRK2 p.Gly2019Ser variant across Latin American countries, with frequencies ranging from 0.002 in Peru to 0.042 in Uruguay [38]. The gene discussed is LRRK2; the disease is Parkinson disease.